Vir enlists J&J vet to run business development; Gilead finds Kite successor to Christi Shaw

→ After grabbing $10 million in funding from the Bill & Melinda Gates Foundation for its HIV vaccine early this month, Vir Biotechnology has now plucked Jeff Calcagno as EVP and CBO. Calcagno hails from J&J, having spent 12 years with the company. Earlier last…